[
  {
    "ts": "2026-01-18T05:56:03+00:00",
    "headline": "Abbott Laboratories (ABT) Positioned to Benefit as Healthcare Sector Enters Recovery Phase",
    "summary": "We recently compiled a list of the 10 Best Investments During A Recession. The seventh stock on our list of best investments is Abbott Laboratories. TheFly reported on January 9 that Bernstein analyst Lee Hambright raised ABT’s price target to $154 from $150, while maintaining an Outperform rating on the stock. The company noted that […]",
    "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-positioned-benefit-055603809.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "fd067799-2fdc-3405-ab2c-c685b189f810",
      "content": {
        "id": "fd067799-2fdc-3405-ab2c-c685b189f810",
        "contentType": "STORY",
        "title": "Abbott Laboratories (ABT) Positioned to Benefit as Healthcare Sector Enters Recovery Phase",
        "description": "",
        "summary": "We recently compiled a list of the 10 Best Investments During A Recession. The seventh stock on our list of best investments is Abbott Laboratories. TheFly reported on January 9 that Bernstein analyst Lee Hambright raised ABT’s price target to $154 from $150, while maintaining an Outperform rating on the stock. The company noted that […]",
        "pubDate": "2026-01-18T05:56:03Z",
        "displayTime": "2026-01-18T05:56:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/59fe7bc4cb7379b8caecd6f09fabc66e",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Abbott Laboratories (ABT) Positioned to Benefit as Healthcare Sector Enters Recovery Phase",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3Xw0K5N1l2hhkKJuE9w9mw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/59fe7bc4cb7379b8caecd6f09fabc66e.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1l5d2S6DavnmvLcoSKfdtg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/59fe7bc4cb7379b8caecd6f09fabc66e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-positioned-benefit-055603809.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-positioned-benefit-055603809.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]